N/A
N=20
Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females
Androgenetic Alopecia
Bottom Line
View on ClinicalTrials.gov: NCT01701271 ↗Enrolled (actual)
20
Serious AEs
—
Results posted
Feb 2016
Primary outcome: Primary: Change of the Amount of Hair Loss in a Pull Test — 2.75 Fallen hair
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Hair loss prevention lotion (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mexis George
- Primary completion
- Jun 2001
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change of the Amount of Hair Loss in a Pull Test |
2.75 | — |
| PRIMARY Change of the Density of the Hair on a Polarized Light Video-camera as a Measure of Efficacy. |
2.75 | — |
| SECONDARY Change of Sebum on a Sebum-meter |
8.8 | — |
Summary
The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Androgenetic Alopecia.
Eligibility Criteria
Inclusion Criteria
- Good state of general health
- Suffering from hair loss
- No pharmacological treatment in progress
- Promise not to change the usual daily routine
- No atopy in the anamnesis
Exclusion Criteria
- Illness
- Good state of hair
- Pharmacological treatment in progress
- Denial of the continuance of the usual daily routine
- Atopy in the anamnesis
Data sourced from ClinicalTrials.gov (NCT01701271). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.